Decision 1994/358 - 94/358/EC: Council Decision of 16 June 1994 accepting, on behalf of the EC, the Convention on the elaboration of a European Pharmacopoeia

Please note

This page contains a limited version of this dossier in the EU Monitor.

1.

Current status

This decision has been published on June 25, 1994 and entered into force on June 16, 1994.

2.

Key information

official title

94/358/EC: Council Decision of 16 June 1994 accepting, on behalf of the European Community, the Convention on the elaboration of a European Pharmacopoeia
 
Legal instrument Decision
Number legal act Decision 1994/358
Original proposal COM(1993)68
CELEX number i 31994D0358

3.

Key dates

Document 16-06-1994
Publication in Official Journal 25-06-1994; Special edition in Slovenian: Chapter 13 Volume 013,Special edition in Romanian: Chapter 13 Volume 014,Special edition in Polish: Chapter 13 Volume 013,Special edition in Finnish: Chapter 13 Volume 026,Special edition in Swedish: Chapter 13 Volume 026,Special edition in Bulgarian: Chapter 13 Volume 014,Special edition in Croatian: Chapter 13 Volume 021,Special edition in Czech: Chapter 13 Volume 013,Special edition in Hungarian: Chapter 13 Volume 013,Special edition in Maltese: Chapter 13 Volume 013,Special edition in Estonian: Chapter 13 Volume 013,OJ L 158, 25.6.1994,Special edition in Lithuanian: Chapter 13 Volume 013,Special edition in Slovak: Chapter 13 Volume 013,Special edition in Latvian: Chapter 13 Volume 013
Effect 16-06-1994; Entry into force Date of document
End of validity 31-12-9999

4.

Legislative text

25.6.1994   

EN

Official Journal of the European Communities

L 158/17

 

COUNCIL DECISION

of 16 June 1994

accepting, on behalf of the European Community, the Convention on the elaboration of a European Pharmacopoeia

(94/358/EC)

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty establishing the European Community, and in particular Articles 113 and 100a thereof, in conjunction with the first sentence of Article 228 (2) and the first subparagraph of Article 228 (3),

Having regard to the proposal from the Commission,

Having regard to the opinion of the European Parliament (1),

Whereas the Convention on the elaboration of a European Pharmacopoeia, which was drawn up within the Council of Europe, aims to harmonize specifications for medicinal substances and pharmaceutical preparations to enable them to circulate in Europe; whereas the monographs of the European Pharmacopoeia become official technical rules applicable within the territories of the countries which are Contracting Parties to the Convention;

Whereas, furthermore, in order to facilitate the free circulation of medicinal products inside its territory, the Community has already unilaterally recognized, by Directives 75/318/EEC (2) and 81/852/EEC (3), the compulsory nature of the European Pharmacopoeia monographs for all medicinal products covered by Community legislation;

Whereas the Member States are Contracting Parties to the Convention; whereas it might be reasonably expected that a growing number of countries, particularly those of eastern Europe, will accede to the Convention;

Whereas the Community constitutes the principal world exporting zone for medicinal products;

Whereas most medicinal products which circulate between the Community and third countries are the subject of monographs drawn up by the European Pharmacopoeia;

Whereas these monographs should therefore serve as the basis for free circulation of these products between the Community and third countries;

Whereas the Community should therefore accede to the Convention in order to facilitate trade with the other Contracting Parties,

HAS DECIDED AS FOLLOWS:

Article 1

The Convention on the elaboration of a European Pharmacopoeia is hereby accepted on behalf of the European Community.

The text of the Convention on the Protocol enabling the Community to accede to it are attached to this Decision.

Article 2

The President of the Council shall, on behalf of the Community, deposit the instrument of accession to the Convention with the Council of Europe, which is the depositary of the Convention and the Protocol.

Article 3

  • 1. 
    Within the Public Health Committee and the European Pharmacopoeia Commission referred to in Article 2 of the Convention, the Community shall be represented by the Commission of the European Communities on the matters referred to in Article 7 (3) of the Convention as amended by Article 3 of the Protocol.
  • 2. 
    The position to be taken within the bodies referred to in paragraph 1 above shall be determined by the Commission in consultation with Member States.
  • 3. 
    The positions to be taken on questions of major importance, in particular with regard to amendments to the obligations on the Member States or when serious divergencies of views emerge in the consultations envisaged in paragraph 2, shall be determined by the Council acting by qualified majority on a proposal from the Commission.

Done at Luxembourg, 16 June 1994.

For the Council

The President

  • A. 
    BALTAS
 

  • (2) 
    Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products (OJ No L 147, 9. 6. 1975, p. 1). Directive as last amended by Directive 93/39/EEC (OJ No L 214, 24. 8. 1993, p....

More

This text has been adopted from EUR-Lex.

5.

Original proposal

 

6.

Sources and disclaimer

For further information you may want to consult the following sources that have been used to compile this dossier:

This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.

 

7.

Full version

This page is also available in a full version containing the summary of legislation, the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand and finally the related cases of the European Court of Justice.

The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.

8.

EU Monitor

The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.